Aimei Health Technology AFJK
NASDAQ AFJK
$12.33 +0.15 (+1.23%)
At close: Aug 20, 2026 · 4:00 PM EDT

Aimei Health Technology (AFJK) EBIT (2024 - 2025)

Aimei Health Technology (AFJK) posted quarterly EBIT of -$130152.0 for Q3 2025, up 34.93% year-over-year from -$96458.8 in Q3 2024, and down 212.84% quarter-over-quarter from -$41604.0 in Q2 2025.

Aimei Health Technology (AFJK) EBIT (2024 - 2025) Analysis & Trends

Aimei Health Technology (AFJK) has reported EBIT for 2 consecutive years, with -$130152.0 the latest figure, recorded in Q3 2025.

  • In Q3 2025, EBIT rose 34.93% year-over-year to -$130152.0; the TTM figure through Sep 2025 stood at -$987191.0 (changed N/A YoY), while the FY2024 annual figure was -$1.1 million, down 3641.47% from the prior year.
  • EBIT retreated to -$130152.0 in Q3 2025 per AFJK's latest filing, from -$41604.0 in the prior quarter.
  • Across five years, EBIT topped out at -$41604.0 in Q2 2025 and bottomed at -$413414.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Launch Two Acquisition 557.86 Mn 557.86 Mn - -194,528.00
2 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - -112,227.00
3 Cantor Equity Partners IV 467.55 Mn 467.55 Mn - -174,182.00
4 GP-Act III Acquisition 401.06 Mn 401.06 Mn - -1.47 Mn
5 Aldel Financial 397.49 Mn 397.49 Mn - -115,742.00
6 Gores Holdings X 381.05 Mn 380.85 Mn - -1.35 Mn
7 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - -
8 Blue Water Acquisition Corp. III 342.12 Mn 342.08 Mn - -197,949.00
9 Berto Acquisition 313.96 Mn 313.81 Mn - -1.62 Mn
10 Aimei Health Technology 49.46 Mn 49.46 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -130,152.00
Jun 30, 2025 -41,604.00
Mar 31, 2025 -413,414.00
Dec 31, 2024 -402,021.00
Sep 30, 2024 -200,019.00
Jun 30, 2024 -309,114.00
Mar 31, 2024 -153,632.00